A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or relapsed renal-cell carcinoma. (Q46625058)
Jump to navigation
Jump to search
scientific article published on 29 July 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or relapsed renal-cell carcinoma. |
scientific article published on 29 July 2005 |
Statements
A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or relapsed renal-cell carcinoma (English)
Monika Jermann
Rolf A Stahel
Marc Salzberg
Thomas Cerny
Markus Joerger
Rudolf Morant
Fritz Egli
Kaspar Rhyner
Jean A Bauer